PhD in molecular biology, virology, genetics, bioengineering, or related field; MS with equivalent experience also acceptable.
2 to 6 years of hands-on experience in gene therapy within biotech or pharma, with recent analysis work.
Experience generating or analyzing data that influenced vector, capsid, promoter, or payload decisions.
Direct experience in at least one area: capsid/vector engineering, promoter design, transduction assays, tropism analysis, or vector immunogenicity.
Deep expertise in one area, with fluency across others.
Strong skills in experimental design, quantitative analysis, and statistics.
Proficient in AI tools like Claude or Cursor, with the ability to critically assess model reasoning.
Responsibilities
Act as the scientific authority on gene therapy, validating AI reasoning against expert knowledge.
Design and curate datasets for benchmarking across various delivery methods.
Develop analysis pipelines in Python to ensure robust data interpretation.
Identify and correct artifacts in experimental data that could mislead conclusions.
Resolve conflicts in data interpretation and propose experiments to clarify uncertainties.
Evaluate trade-offs in vector design, balancing factors like tropism and payload capacity.
Critically assess AI-generated conclusions, ensuring scientific rigor in decision-making.
Benefits
Health, dental, and vision insurance fully covered for employees; 50% for dependents.
401(k) plan available (no match).
15 days of PTO to start, increasing with promotions.
Guaranteed base salary paid bi-monthly for US employees.
Flexible work location: remote or onsite in San Francisco, with a preference for onsite collaboration.
Full Job Description
We're seeking an AI Biologist to join our Gene Therapy Discovery team, pushing what AI can achieve in vector and payload design.
About the Role
You will be the scientific authority on ground truth, testing whether agents can reason like an expert gene therapy scientist. The data misleads constantly: a genome copy is not an expressed transgene, a titer is not an infectious unit, and enrichment in a library screen is not tropism. Knowing what the evidence actually supports is the work. You will build the tasks and datasets behind our benchmarks across AAV, lentiviral, and non-viral delivery, from target tissue to candidate nomination.
Build the task
Write gold-standard answers with the rationale an experienced vector scientist would defend.
Design scenarios across the discovery arc: capsid or vector selection, promoter and regulatory element choice, payload design within packaging limits, transduction and expression, tropism, and early immunogenicity triage.
Curate datasets from real programs: barcoded library NGS at DNA and RNA level, qPCR and ddPCR genome titers, capsid titers by ELISA or AUC, infectious unit assays, transduction across cell types and MOIs, payload expression, single-cell or spatial tropism, biodistribution, innate immune readouts.
Build analysis pipelines in Python where useful, with tolerances that hold across replicates and analytical methods.
Set the hard calls
Catch the artifact. A variant enriched because it replicates or packages well, not because it transduces. DNA-level barcode recovery that counts uptake rather than completed transduction, so variants failing a late step still score. Barcode frequencies skewed by GC content, RT-PCR efficiency, or excess PCR cycles. An empty-to-full ratio that moves depending on whether it came from AUC, mass photometry, or a capsid-to-genome titer ratio, which overestimates empties. Partial genomes that count toward vector genome titer and read as infectious but add no potency. Transgene mRNA present with no detectable protein.
Adjudicate conflicts. In vitro transduction against in vivo tropism. Weak bulk expression as inefficient delivery or as tight tropism for a rare cell type. A DNA-level transduction deficit against promoter silencing. Pre-existing neutralizing antibodies against intrinsic capsid performance. Then name the experiment that settles it.
Weigh the tradeoffs. Tropism breadth versus specificity, expression level versus durability, payload size versus packaging capacity, promoter strength versus cell-type restriction, and when a potency gain costs immunogenicity or manufacturability.
Judge the agent
Interrogate reasoning step by step, and challenge conclusions that would not survive a project review.
Pinpoint where agents go wrong: why the step fails, what an expert would do, what evidence would change the call.
Score confidence, rewarding explicit uncertainty over overconfident calls on ambiguous data.
Requirements
PhD in molecular biology, virology, genetics, bioengineering, or a related field. An MS with equivalent hands-on program experience also qualifies.
2 to 6 years hands-on in gene therapy at a biotech or pharma, with your own analysis work in the last two years.
You have personally generated or analyzed data that decided which vector, capsid, promoter, or payload advanced, and you can name the threshold and the call.
Direct experience with at least one of: capsid or vector engineering and library screening, promoter and regulatory element design, transduction and expression assays, tropism or biodistribution analysis, or vector immunogenicity.
Deep in one of those, fluent across the others.
Strong experimental design, quantitative analysis, and statistics.
AI-ready from day one: daily use of Claude, Cursor, or similar, with the judgment to spot where model reasoning is technically correct but scientifically unsound, and the confidence to overrule it.
Bonus: Python or R for your own analyses. Gene editing delivery or non-viral delivery (LNP, nanoparticle, electroporation).
Compensation
$140K-$180K OTE (on-target earnings), with no ceiling.
Your pay is your OTE times your weekly quota attainment. Hit quota, earn your OTE; double it, earn double. Example: $150K OTE at double quota = $300K.
Your first 4 weeks (ramp) are paid at full OTE while you learn our workflows.
You're paid full OTE whenever quota can't fairly apply: when a new project is starting, the platform goes down, or we pull you onto a special project.
Benefits & Employment
In the US: full-time W-2
Guaranteed floor ("base salary") set by your state, paid on the 15th and last day of every month
Health, dental, vision: 100% covered for you, 50% for dependents
401(k) (no match)
PTO: 15 days to start, more as you're promoted
Outside the US: contractor
Paid on performance. We want our team to have stability, so we pay 60% of your monthly OTE up front as an advance, balanced against your earnings in later paychecks.
US benefits don't apply.
Growth
Two tracks, based on output.
Individual contributor: six levels, so up to five promotions, with OTE rising at each one.
Management: after your first promotion, you can move into managing a pod or keep growing on the IC track.
Location & Work Authorization
Location: remote or onsite at our Mission Bay office in San Francisco. Onsite is preferred: working side by side is how we share knowledge and keep our work rigorous. We have a global team, and remote teammates regularly visit the office.
Work authorization: we sponsor H-1B (new and transfers), O-1, and TN, and support STEM OPT.
Interview Process
Apply. If your profile matches, we'll send you a take-home project.
Take-home project (HackerRank). We review it as soon as it arrives.
Technical interview with a Member of Technical Staff (pod lead).